Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Large-scale testing (Phase 3)Study completedNCT00377156What this trial is testingStereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain MetastasesWho this might be right forBreast CancerCognitive/Functional EffectsLung Cancer+2 more Alliance for Clinical Trials in Oncology 213
Testing effectiveness (Phase 2)Study completedNCT02595905What this trial is testingCisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain MetastasesWho this might be right forMetastatic BRCA Hereditary Breast CarcinomaMetastatic Breast CarcinomaMetastatic Malignant Neoplasm in the Brain+3 more National Cancer Institute (NCI) 344
Testing effectiveness (Phase 2)Ended earlyNCT00437073What this trial is testingBrain Metastases In ErbB2-Positive Breast CancerWho this might be right forNeoplasms, Breast GlaxoSmithKline 22
Very early researchEnded earlyNCT03796273What this trial is testingKetoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain MetastasesWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8AstrocytomaBreast Carcinoma Metastatic in the Brain+5 more Wake Forest University Health Sciences 15
Testing effectiveness (Phase 2)Study completedNCT00617539What this trial is testingIrinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain MetastasesWho this might be right forBreast CancerMetastatic Cancer University of California, San Francisco 30
Testing effectiveness (Phase 2)Study completedNCT01386580What this trial is testingAn Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.Who this might be right forBrain MetastasesLung CancerBreast Cancer+2 more BBB-Therapeutics B.V. 84
Testing effectiveness (Phase 2)Study completedNCT02614794What this trial is testingTucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast CancerWho this might be right forHER2 Positive Breast Cancer Seagen Inc. 612
Testing effectiveness (Phase 2)Ended earlyNCT01217411What this trial is testingRO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast CancerWho this might be right forAdult Solid NeoplasmExtensive Stage Lung Small Cell CarcinomaHER2/Neu Negative+10 more National Cancer Institute (NCI) 5
Large-scale testing (Phase 3)Ended earlyNCT04588246What this trial is testingComparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic RadiosurgeryWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+9 more NRG Oncology 19
Testing effectiveness (Phase 2)Study completedNCT02048059What this trial is testingANG1005 in Breast Cancer Patients With Recurrent Brain MetastasesWho this might be right forBreast CancerBrain Metastases Angiochem Inc 72
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT00450866What this trial is testingEpothilone B in Treating Patients With CNS Metastases From Breast CancerWho this might be right forBreast CancerMetastatic Cancer David Peereboom, MD 55
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Ended earlyNCT00227656What this trial is testingCapecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast CancerWho this might be right forBreast CancerMetastatic Cancer M.D. Anderson Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT00992602What this trial is testingLiposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast CancerWho this might be right forCentral Nervous System MetastasesLeptomeningeal MetastasesRecurrent Breast Cancer+2 more University of Washington 3
Testing effectiveness (Phase 2)Looking for participantsNCT06907043What this trial is testingPARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.Who this might be right forAdvanced Solid Tumors Eikon Therapeutics 130
Testing effectiveness (Phase 2)Study completedNCT02312622What this trial is testingPhase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast CancerWho this might be right forStage IV Non-small Cell Lung Cancer (NSCLC)Recurrent Non-small Cell Lung Cancer (NSCLC)Extensive-stage Small Cell Lung Cancer (SCLC)+3 more Joel Neal 27
Not applicableNo Longer AvailableNCT02755987What this trial is testingExpanded Access to ANG1005 for Individual PatientsWho this might be right forAnaplastic AstrocytomaAnaplastic OligodendrogliomaBreast Cancer With Recurrent Brain Metastases+1 more Angiochem Inc
Large-scale testing (Phase 3)Looking for participantsNCT03418961What this trial is testingS1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityWho this might be right forCardiotoxicityHER2/Neu PositiveMetastatic Malignant Neoplasm in the Brain+2 more SWOG Cancer Research Network 491